Abbott India Ltd share price logo

Abbott India Ltd Share Price

(ABBOTINDIA)

₹29909.31.25%

as on 04:01PM, 03 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Abbott India Ltd Performance

  • Day's Low

    Day's High

    ₹29,740
    Day's Price Range
    ₹30,398
  • 52 Week's Low

    52 Week's High

    ₹25,200
    52-Week Price Range
    ₹31,898.95
1 Month Return-5.27 %
3 Month Return+ 0.17 %
1 Year Return+ 10.58 %
Previous Close₹29,540.90
Open₹29,800.00
Volume10.99K
Upper Circuit₹35,449.05
Lower Circuit₹23,632.75
Market Cap₹62,774.41Cr

Abbott India Ltd Fundamentals

P/E Ratio

0

PEG Ratio

0

Market Cap

₹62,774.41 Cr

P/B Ratio

15.48

EPS

35.67

Dividend Yield

0

Sector

Pharmaceuticals

ROE

34.88

Abbott India Ltd Analyst Rating

based on 7 analysts

BUY

71.43%

Buy

0.00%

Hold

28.57%

Sell

Based on 7 analysts offering long term price targets for Abbott India Ltd. An average target of ₹29838.57

Source: S&P Global Market Intelligence

Abbott India Ltd Share analysis

Abbott India Ltd price forecast by 7 analysts

Upside of1.01%

High

₹34000

Target

₹29838.57

Low

₹17872

Abbott India Ltd target price ₹29838.57, a slight upside of 1.01% compared to current price of ₹29909.3. According to 7 analysts rating.

Source: S&P Global Market Intelligence

Key events for Abbott India Ltd

  • Abbott India Faces Legal Scrutiny Over Sponsorship - 05 Mar, 2025

    Abbott Nutrition is under scrutiny for sponsoring a pediatric summit, violating the IMS Act prohibiting baby food companies from funding medical conferences. The union health ministry has sought clarification from the Indian Academy of Paediatrics regarding this violation.
  • Abbott India Shares Reach Record High Amid Gains - 04 Mar, 2025

    Abbott India Ltd shares surged nearly 2% to an all-time high of ₹31,750, reflecting a 20.49% increase over the past month. The company reported a 12.32% revenue increase and a 16% rise in profit after tax for Q3 FY24-25.
  • Abbott India Stock Price and Trading Recommendations - 25 Feb, 2025

    Abbott India Ltd's current market price is ₹29,813, with a recommended buy range of ₹29,000–30,000, profit goal of ₹34,000, and stop loss at ₹27,700.
  • Abbott India Management Change Announcement - 20 Feb, 2025

    Abbott India announced the resignation of Namita Shah, Associate Director of New Product Introduction and Therapy Area Strategy, effective April 15, 2025, to pursue other opportunities.
  • Abbott India Advances Healthcare Innovations - 15 Feb, 2025

    Abbott India focuses on enhancing patient access to innovative health solutions, including the AVEIR VR leadless pacemaker and seven newly launched biosimilars. The company emphasizes collaboration in digital healthcare and continues to drive innovation from its Mumbai hub.
  • ICICI Securities Maintains Buy Rating for Abbott India - 09 Feb, 2025

    ICICI Securities maintains a 'BUY' rating for Abbott India with a target price of Rs 32,700, citing strong revenue growth and a robust product portfolio. Despite minor cuts to FY25-26E EBITDA and PAT estimates, the outlook remains positive due to the company's focus on domestic formulations and strong financials.
  • Abbott India Ltd Continues Upward Trend - 07 Feb, 2025

    Abbott India Ltd rose 1.23%, marking its fifth consecutive gain. The stock is currently at Rs 29,440, up 4.18% over the past year, despite a 0.57% decline in the last month. The Nifty Pharma index has also seen a decline of 4.11% in the same period.
  • Abbott India Reports Strong Q3 Earnings Growth - 05 Feb, 2025

    Abbott India reported a 16% year-on-year increase in Q3 net profit to Rs 360.78 crore, with revenue rising 12.32% to Rs 1,614.28 crore, leading to a 6.17% surge in shares.

Insights on Abbott India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.69% to 7.77% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 53.8% return, outperforming this stock by 43.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 74.99% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 126.6% return, outperforming this stock by 58.3%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.16% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.85% to 15.84% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ABBOTINDIA stock has moved down by -3.4%

Abbott India Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹3,850.06Cr (-)₹4,233.27Cr (↑9.95%)₹4,563.66Cr (↑7.80%)₹5,201.54Cr (↑13.98%)
Total Liabilities₹1,247.90Cr (-)₹1,413.48Cr (↑13.27%)₹1,375.12Cr (↓2.71%)₹1,502.65Cr (↑9.27%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹626.13Cr (-)₹726.74Cr (↑16.07%)₹947.66Cr (↑30.40%)₹893.39Cr (↓5.73%)₹1,212.81Cr (↑35.75%)

Abbott India Ltd Index Inclusions

BSE Mid-Cap

₹41,796.08

0.31 (128.43%)

S&P BSE 250 LargeMidCap

₹9,965.67

-0.19 (-19.21%)

BSE 200

₹10,529.35

-0.21 (-22.37%)

BSE Healthcare

₹41,870.79

1.82 (748.02%)

Nifty MNC

₹26,076.60

-0.09 (-24.7%)

S&P BSE Low Volatility

₹1,698.84

-0.21 (-3.64%)

S&P BSE 150 MidCap

₹14,492.74

0.17 (24.16%)

Nifty 500

₹21,243.40

-0.1 (-22.25%)

S&P BSE Quality

₹1,663.96

-0.13 (-2.12%)

Nifty Healthcare

₹13,849.50

1.98 (268.35%)

S&P BSE 400 MidSmallCap

₹10,851.36

0.32 (35.01%)

BSE 500

₹33,420.86

-0.12 (-38.79%)

Nifty LargeMidcap 250

₹14,797.90

-0.04 (-6.5%)

NIFTY PHARMA

₹21,423.55

2.25 (470.7%)

Nifty Midcap 150

₹19,238.40

0.2 (37.65%)

Nifty MidSmallcap 400

₹17,823.20

0.37 (65.95%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Abbott India Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
74.99%
0.00
Foreign Institutions
0.16%
0.00
Mutual Funds
7.77%
1.11
Retail Investors
15.84%
-0.05
Others
1.23%
-5.90

Abbott India Ltd Key Indicators

Details2002
Earning Per Share (₹)35.67
Details20202021202220232024
Return On Equity %26.7127.4429.4631.634.88
Details2002
Book Value Per Share (₹)106.54

Abbott India Ltd Earnings and Dividends

  • Abbott India Ltd Earnings Results

    Abbott India Ltd’s net profit jumped 16.01% since last year same period to ₹360.78Cr in the Q3 2024-2025. On a quarterly growth basis, Abbott India Ltd has generated 0.61% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Abbott India Ltd Dividends May,2024

    In the quarter ending March 2024, Abbott India Ltd has declared dividend of ₹410 - translating a dividend yield of 2.46%.

    Read More about Dividends

Abbott India Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Abbott India Ltd is currently in a Bearish trading position according to technical analysis indicators.

Abbott India Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹62,774.41 Cr17.37%0.53NANA
BUY₹13,532.31 Cr-2.34%0.52₹602 Cr₹2,851 Cr
BUY₹67,842.90 Cr40.56%0.56₹3,168 Cr₹29,001 Cr
HOLD₹89,670.54 Cr44.91%0.64₹3,854 Cr₹19,547 Cr
BUY₹47,037.28 Cr25.36%0.56₹589 Cr₹3,453 Cr

About Abbott India Ltd

Abbott India Ltd is a leading multinational pharmaceutical company in India, with its headquarters in Mumbai. It has manufacturing facilities in Goa and independent contract/third party manufacturers based across the country. The company provides products and solutions across therapeutic areas such as Womens Health, Gastroenterology, Central Nervous System, Metabolics, MultiSpecialty, Vaccines and Consumer Health. In 2002, they sold their Jejuri Undertakings with assets and liabilities as a going concern. In 2003, they amalgamated Knoll Pharmaceuticals Ltd with the company. In 2004, they started capsule production with a capacity of 27 million nos. and in 2005, they further increased the capacity to 56 million nos. and started a new project of producing nutritional products with installed capacity of 600 tonnes. In 2006, the production capacity of Tablets was also increased by 236 million nos to 686 million. In 2008, they launched Digene Total buffered pantoprazole tablet, Bruge, and Thyronorm 150 Digene along with Sugar Free Tablet and Gel. In 2018, Abbott India Ltd formed a new Business Unit GI Advance which followed a Build Operate Transfer model. During the year 2020-21, the company made an innovation in Brufen Coating formula leading to 50% increase in coating installed capacity. It further executed 8 new studies and published 8 articles in major indexed journals. Abbott India also launched 10 new products in various therapy segments leading to their recognition as The Most Innovative MNC of the Year 2019 at the 12th Pharma Leaders Award. The Drug Price Control Order 2013 brought several products of Abbott India under price control, leading to an adverse impact on sales and profits. They also received approvals to conduct phase 3 studies in adults/eldery and pediatric for their Influvac Quadrivalent Vaccine QIV Program. Abbott India has been making continuous efforts for portfolio expansion launching unique products and leveraging technology for better healthcare outcomes.

Listing date: 03 Nov, 1994
Chairperson Name: Munir Shaikh
OrganisationAbbott India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Abbott India Ltd

What is Abbott India Ltd price today?

Abbott India Ltd share price today stands at ₹29909.3, Open: ₹29800, Previous Close: ₹29540.9, High: ₹30398, Low: ₹29740, 52 Week High: ₹31898.95, 52 Week Low: ₹25200.

How to Buy Abbott India Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Abbott India Ltd shares

What are today's traded volumes of Abbott India Ltd?

Today's traded volume of Abbott India Ltd(ABBOTINDIA) is 10.99K.

What is today's market capitalisation of Abbott India Ltd?

Today's market capitalisation of Abbott India Ltd(ABBOTINDIA) is ₹62774.41Cr.

What is the 52 Week High and Low Range of Abbott India Ltd?

Abbott India Ltd (ABBOTINDIA)
Price
52 Week High
₹31898.95
52 Week Low
₹25200

How much percentage Abbott India Ltd is down from its 52 Week High?

Abbott India Ltd (ABBOTINDIA) share price is ₹29909.3. It is down -6.24% from its 52 Week High price of ₹31898.95

How much percentage Abbott India Ltd is up from its 52 Week low?

Abbott India Ltd (ABBOTINDIA) share price is ₹29909.3. It is up 18.69% from its 52 Week Low price of ₹25200